Topotecan and Cisplatin Versus Etoposide and Carboplatin in 1st Line Treatment of Patients With Small Cell Lung Cancer and Extensive Disease (SCLC-ED)
This study is currently recruiting participants.
Verified June 2011 by Danish Oncological Lung Cancer Group
Sponsor:
Danish Oncological Lung Cancer Group
Information provided by:
Danish Oncological Lung Cancer Group
ClinicalTrials.gov Identifier:
NCT00812266
First received: December 19, 2008
Last updated: June 23, 2011
Last verified: June 2011
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | January 2015 |
| Estimated Primary Completion Date: | January 2013 (Final data collection date for primary outcome measure) |